ArticleJournal of cardiothoracic surgery2026
Research on the author collaboration network and institutional influence in the transcatheter aortic valve replacement field based on CiteSpace: analysis of the top one hundred highly cited articles.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter aortic valve replacement (TAVR) has revolutionised the management of severe aortic stenosis, expanding its applications from high-risk to intermediate- and low-risk patients. Understanding the key contributors, collaborative networks and thematic evolutions in TAVR research can inform future investigations.
methodsThis bibliometric study screened the Web of Science Core Collection for the top 100 highly cited TAVR-related publications between 2010 and 2025. We utilised CiteSpace (version 6.2.R1) to analyse author, country and institutional collaborations, along with references, keywords and citation bursts.
resultsThe USA emerged as the most influential country, with leading institutions including the Cleveland Clinic Foundation and Columbia University. Authors such as Martin B. Leon, Rebecca Hahn and Raj R. Makkar held central collaborative roles. Reference co-citation and keyword analyses showed an early emphasis on procedural feasibility and comparisons with surgical aortic valve replacement, followed by a shift toward clinical outcomes, complications (e.g. permanent pacemaker implantation, infective endocarditis) and long-term management. Landmark trials and guidelines (e.g. PARTNER, 2014 American Heart Association/American College of Cardiology Valvular Heart Disease Guideline) exhibited significant citation bursts, underscoring their foundational impact.
conclusionsResearch on TAVR has evolved in tandem with technological advances and the expansion of clinical indications. Sustained international collaboration and continued study of long-term outcomes, device durability and complication mitigation will be pivotal for optimising TAVR’s therapeutic impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.